PD-1 Inhibitors in Elderly and Immunocompromised Patients with Advanced or Metastatic Cutaneous Squamous Cell Carcinoma

SIMPLE SUMMARY: This article assesses the efficacy and safety of cemiplimab and pembrolizumab within a complex cohort of cancer patients diagnosed with locally advanced cutaneous squamous cell carcinoma or metastatic cutaneous squamous cell carcinoma. This cohort encompassed individuals with immunos...

Descripción completa

Detalles Bibliográficos
Autores principales: Yakobson, Alexander, Abu Jama, Ashraf, Abu Saleh, Omar, Michlin, Regina, Shalata, Walid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452426/
https://www.ncbi.nlm.nih.gov/pubmed/37627069
http://dx.doi.org/10.3390/cancers15164041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452426/
https://www.ncbi.nlm.nih.gov/pubmed/37627069
http://dx.doi.org/10.3390/cancers15164041

Ejemplares similares